169 related articles for article (PubMed ID: 26868056)
21. Association of myeloperoxidase promotor polymorphism with cirrhosis in patients with hereditary hemochromatosis.
Osterreicher CH; Datz C; Stickel F; Hellerbrand C; Penz M; Hofer H; Wrba F; Penner E; Schuppan D; Ferenci P
J Hepatol; 2005 Jun; 42(6):914-9. PubMed ID: 15885363
[TBL] [Abstract][Full Text] [Related]
22. Abdominal pain and cirrhosis at diagnosis of hemochromatosis: Analysis of 219 referred probands with HFE p.C282Y homozygosity and a literature review.
Barton JC; Barton JC; Patel N; McLaren GD
PLoS One; 2021; 16(12):e0261690. PubMed ID: 34932603
[TBL] [Abstract][Full Text] [Related]
23. Mutations of the HFE gene in patients with hepatocellular carcinoma.
Cauza E; Peck-Radosavljevic M; Ulrich-Pur H; Datz C; Gschwantler M; Schöniger-Hekele M; Hackl F; Polli C; Rasoul-Rockenschaub S; Müller C; Wrba F; Gangl A; Ferenci P
Am J Gastroenterol; 2003 Feb; 98(2):442-7. PubMed ID: 12591066
[TBL] [Abstract][Full Text] [Related]
24. Hereditary hemochromatosis type 1 phenotype modifiers in Italian patients. The controversial role of variants in HAMP, BMP2, FTL and SLC40A1 genes.
Radio FC; Majore S; Aurizi C; Sorge F; Biolcati G; Bernabini S; Giotti I; Torricelli F; Giannarelli D; De Bernardo C; Grammatico P
Blood Cells Mol Dis; 2015 Jun; 55(1):71-5. PubMed ID: 25976471
[TBL] [Abstract][Full Text] [Related]
25. Serum ferritin concentration predicts hepatic fibrosis better than hepatic iron concentration in human HFE-Haemochromatosis.
Wood MJ; Crawford DHG; Wockner LF; Powell LW; Ramm GA
Liver Int; 2017 Sep; 37(9):1382-1388. PubMed ID: 28231420
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis.
de Tayrac M; Roth MP; Jouanolle AM; Coppin H; le Gac G; Piperno A; Férec C; Pelucchi S; Scotet V; Bardou-Jacquet E; Ropert M; Bouvet R; Génin E; Mosser J; Deugnier Y
J Hepatol; 2015 Mar; 62(3):664-72. PubMed ID: 25457201
[TBL] [Abstract][Full Text] [Related]
27. Interaction between haemochromatosis and transferrin receptor genes in hepatocellular carcinoma.
Beckman LE; Hägerstrand I; Stenling R; Van Landeghem GF; Beckman L
Oncology; 2000 Nov; 59(4):317-22. PubMed ID: 11096344
[TBL] [Abstract][Full Text] [Related]
28. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.
Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G
Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249
[TBL] [Abstract][Full Text] [Related]
29. Carriage of HFE mutations and outcome of surgical resection for hepatocellular carcinoma in cirrhotic patients.
Pirisi M; Toniutto P; Uzzau A; Fabris C; Avellini C; Scott C; Apollonio L; Beltrami CA; Bresadola F
Cancer; 2000 Jul; 89(2):297-302. PubMed ID: 10918159
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of A1AT (S and Z) and HFE (C282Y and H63D) gene mutations in Egyptian cases with HCV liver cirrhosis.
Settin A; El-Bendary M; Abo-Al-Kassem R; El Baz R
J Gastrointestin Liver Dis; 2006 Jun; 15(2):131-5. PubMed ID: 16802007
[TBL] [Abstract][Full Text] [Related]
31. Hereditary hemochromatosis.
Crownover BK; Covey CJ
Am Fam Physician; 2013 Feb; 87(3):183-90. PubMed ID: 23418762
[TBL] [Abstract][Full Text] [Related]
32. [Hemochromatosis International: therapeutic recommendations in
Zhang W; Huang J; Ou XJ; You H; Jia JD
Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):980-981. PubMed ID: 31941259
[TBL] [Abstract][Full Text] [Related]
33. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda.
Sampietro M; Piperno A; Lupica L; Arosio C; Vergani A; Corbetta N; Malosio I; Mattioli M; Fracanzani AL; Cappellini MD; Fiorelli G; Fargion S
Hepatology; 1998 Jan; 27(1):181-4. PubMed ID: 9425935
[TBL] [Abstract][Full Text] [Related]
34. Testing and Management of Iron Overload After Genetic Screening-Identified Hemochromatosis.
Savatt JM; Johns A; Schwartz MLB; McDonald WS; Salvati ZM; Oritz NM; Masnick M; Hatchell K; Hao J; Buchanan AH; Williams MS
JAMA Netw Open; 2023 Oct; 6(10):e2338995. PubMed ID: 37870835
[TBL] [Abstract][Full Text] [Related]
35. TGF-beta1 codon 25 gene polymorphism is associated with cirrhosis in patients with hereditary hemochromatosis.
Osterreicher CH; Datz C; Stickel F; Hellerbrand C; Penz M; Hofer H; Wrba F; Penner E; Schuppan D; Ferenci P
Cytokine; 2005 Jul; 31(2):142-8. PubMed ID: 15941661
[TBL] [Abstract][Full Text] [Related]
36. Toll-like receptor 4 gene polymorphism modulates phenotypic expression in patients with hereditary hemochromatosis.
Krayenbuehl PA; Hersberger M; Truninger K; Müllhaupt B; Maly FE; Bargetzi M; Schulthess G
Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):835-41. PubMed ID: 19809335
[TBL] [Abstract][Full Text] [Related]
37. Mutations of the HFE gene and the risk of hepatocellular carcinoma.
Racchi O; Mangerini R; Rapezzi D; Gaetani GF; Nobile MT; Picciotto A; Ferraris AM
Blood Cells Mol Dis; 1999; 25(5-6):350-3. PubMed ID: 10660482
[TBL] [Abstract][Full Text] [Related]
38. - 174 G>C IL-6 polymorphism and primary iron overload in male patients.
Tetzlaff WF; Meroño T; Botta EE; Martín ME; Sorroche PB; Boero LE; Castro M; Frechtel GD; Rey J; Daruich J; Cerrone GE; Brites F
Ann Hematol; 2018 Sep; 97(9):1683-1687. PubMed ID: 29656314
[TBL] [Abstract][Full Text] [Related]
39. Utility of hepatic or total body iron burden in the assessment of advanced hepatic fibrosis in HFE hemochromatosis.
Chin J; Powell LW; Ramm LE; Ayonrinde OT; Ramm GA; Olynyk JK
Sci Rep; 2019 Dec; 9(1):20234. PubMed ID: 31882912
[TBL] [Abstract][Full Text] [Related]
40. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
